Episode 383: PREMIUM – What IMPACT can we have on COPD?
In episode 383, James and Mike go over the IMPACT trial that looks at triple inhaler therapy for patients with COPD. We talk about how, unfortunately, the impact is not that impactful and then put all the results into context with the issues of placebo, patents and cost.
Show Notes
1) Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
2) Price Comparison of Commonly Prescribed Pharmaceuticals in Alberta 2018
Listening to this episode is for premium podcast members only. If you already have a membership, login to your account. If you aren't yet a premium subscriber, sign up today!
